{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:40:25Z","timestamp":1759178425605,"version":"3.44.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01919-3","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:21:44Z","timestamp":1759173704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of non-alcoholic fatty liver disease in suspected coronary artery disease patients: prognostic value and incremental predictive utility over cardiovascular risk factors and CCTA"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8135-7807","authenticated-orcid":false,"given":"Changqin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9641-3170","authenticated-orcid":false,"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengnan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruili","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xixia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6797-8108","authenticated-orcid":false,"given":"Qiang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6763-8463","authenticated-orcid":false,"given":"Zhaoqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"issue":"4","key":"1919_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u201347.","journal-title":"Hepatology"},{"issue":"7","key":"1919_CR2","first-page":"543","volume":"29","author":"R Medina-Santill\u00e1n","year":"2013","unstructured":"Medina-Santill\u00e1n R, L\u00f3pez-Vel\u00e1zquez JA, Ch\u00e1vez-Tapia N, et al. Hepatic manifestations of metabolic syndrome. Diabetes Metab Res Rev. 2013;29(7):543\u201350.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"1919_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jhep.2022.08.008","volume":"78","author":"A Hadjihambi","year":"2023","unstructured":"Hadjihambi A, Konstantinou C, Klohs J, et al. Partial MCT1 invalidation protects against diet-induced non-alcoholic fatty liver disease and the associated brain dysfunction. J Hepatol. 2023;78(1):180\u201390. https:\/\/doi.org\/10.1016\/j.jhep.2022.08.008.","journal-title":"J Hepatol"},{"issue":"10","key":"1919_CR4","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.2337\/dc15-1182","volume":"39","author":"G Musso","year":"2016","unstructured":"Musso G, Cassader M, Cohney S, et al. Fatty liver and chronic kidney disease: novel mechanistic insights and therapeutic opportunities. Diabetes Care. 2016;39(10):1830\u201345. https:\/\/doi.org\/10.2337\/dc15-1182.","journal-title":"Diabetes Care"},{"issue":"8","key":"1919_CR5","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","volume":"73","author":"EP Stahl","year":"2019","unstructured":"Stahl EP, Dhindsa DS, Lee SK, et al. Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(8):948\u201363.","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"1919_CR6","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/eurjpc\/zwab120","volume":"28","author":"K Ichikawa","year":"2021","unstructured":"Ichikawa K, Miyoshi T, Osawa K, et al. Incremental prognostic value of nonalcoholic fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease. Eur J Prev Cardiol. 2021;28(18):2059\u201366.","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"1919_CR7","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/eurjpc\/zwab212","volume":"29","author":"L Alon","year":"2022","unstructured":"Alon L, Corica B, Raparelli V, et al. Risk of cardiovascular events in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Prev Cardiol. 2022;29(6):938\u201346.","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"1919_CR8","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.27368","volume":"61","author":"M Ekstedt","year":"2015","unstructured":"Ekstedt M, Hagstr\u00f6m H, Nasr P, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015;61(5):1547\u201354.","journal-title":"Hepatology"},{"issue":"2","key":"1919_CR9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/hep.25593","volume":"56","author":"D Kim","year":"2012","unstructured":"Kim D, Choi S Y, Park E H, et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology. 2012;56(2):605\u201313.","journal-title":"Hepatology"},{"key":"1919_CR10","doi-asserted-by":"crossref","unstructured":"Oni ET, Agatston AS, Blaha MJ, et al. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care? Atherosclerosis. 2013;230(2):258\u201367.","DOI":"10.1016\/j.atherosclerosis.2013.07.052"},{"issue":"7","key":"1919_CR11","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.jcmg.2020.11.012","volume":"14","author":"GBJ Mancini","year":"2021","unstructured":"Mancini GBJ, Leipsic J, Budoff MJ, et al. CT angiography followed by invasive angiography in patients with moderate or severe ischemia-insights from the ISCHEMIA trial. JACC Cardiovasc imaging. 2021;14(7):1384\u201393.","journal-title":"JACC Cardiovasc imaging"},{"issue":"12","key":"1919_CR12","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/2012.jama.11274","volume":"308","author":"JK Min","year":"2012","unstructured":"Min JK, Leipsic J, Pencina MJ, et al. Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA. 2012;308(12):1237\u201345.","journal-title":"JAMA"},{"issue":"18","key":"1919_CR13","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1016\/j.jacc.2018.07.043","volume":"72","author":"BL N\u00f8rgaard","year":"2018","unstructured":"N\u00f8rgaard BL, Terkelsen CJ, Mathiassen ON, et al. Coronary CT angiographic and flow reserve-guided management of patients with stable ischemic heart disease. J Am Coll Cardiol. 2018;72(18):2123\u201334.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1919_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacc.2018.10.056","volume":"73","author":"RS Driessen","year":"2019","unstructured":"Driessen RS, Danad I, Stuijfzand WJ, et al. Comparison of coronary computed tomography angiography, fractional flow reserve, and perfusion imaging for ischemia diagnosis. J Am Coll Cardiol. 2019;73(2):161\u201373.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1919_CR15","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jcmg.2016.07.005","volume":"10","author":"BS Ko","year":"2017","unstructured":"Ko BS, Cameron JD, Munnur RK, et al. Noninvasive CT-derived FFR based on structural and fluid analysis: a comparison with invasive FFR for detection of functionally significant stenosis. JACC Cardiovasc imaging. 2017;10(6):663\u201373.","journal-title":"JACC Cardiovasc imaging"},{"issue":"9","key":"1919_CR16","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s00380-020-01606-z","volume":"35","author":"K Miyajima","year":"2020","unstructured":"Miyajima K, Motoyama S, Sarai M, et al. On-site assessment of computed tomography-derived fractional flow reserve in comparison with myocardial perfusion imaging and invasive fractional flow reserve. Heart Vessels. 2020;35(9):1331\u201340.","journal-title":"Heart Vessels"},{"issue":"3","key":"1919_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/ehjci\/jey104","volume":"20","author":"S Fujimoto","year":"2019","unstructured":"Fujimoto S, Kawasaki T, Kumamaru KK, et al. Diagnostic performance of on-site computed tomography-derived fractional flow reserve based on fluid-structure interactions: comparison with invasive fractional flow reserve and instantaneous wave-free ratio. Eur Heart J Cardiovasc imaging. 2019;20(3):343\u201352.","journal-title":"Eur Heart J Cardiovasc imaging"},{"issue":"5","key":"1919_CR18","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jcmg.2015.11.025","volume":"10","author":"BL N\u00f8rgaard","year":"2017","unstructured":"N\u00f8rgaard BL, Hjort J, Gaur S, et al. Clinical use of coronary CTA-Derived FFR for decision-making in stable CAD. JACC Cardiovasc imaging. 2017;10(5):541\u201350.","journal-title":"JACC Cardiovasc imaging"},{"issue":"4","key":"1919_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/ehjci\/jex068","volume":"19","author":"JM Jensen","year":"2018","unstructured":"Jensen JM, B\u00f8tker HE, Mathiassen ON, et al. Computed tomography-derived fractional flow reserve testing in stable patients with typical angina pectoris: Influence on downstream rate of invasive coronary angiography. Eur Heart J Cardiovasc imaging. 2018;19(4):405\u201314.","journal-title":"Eur Heart J Cardiovasc imaging"},{"key":"1919_CR20","doi-asserted-by":"crossref","unstructured":"Knuuti J, Wijns W, Saraste A, et al. ESC guidelines for the diagnosis and management of chronic coronary syndromes: the task force for the diagnosis and management of chronic coronary syndromes of the European society of cardiology (ESC). Eur Heart J. 2019. 2020;41(3):407\u201377.","DOI":"10.15829\/1560-4071-2020-2-3757"},{"key":"1919_CR21","unstructured":"Members WC, Gulati M, Levy PD, et al. AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines [published correction appears in J Am Coll Cardiol. J Am Coll Cardiol. 2021. 2021;78(22):e187\u2013285."},{"issue":"4","key":"1919_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/jcdd9040116","volume":"9","author":"H Wienemann","year":"2022","unstructured":"Wienemann H, Langenbach MC, Mauri V, et al. Feasibility and comparison of resting full-cycle ratio and computed tomography fractional flow reserve in patients with severe aortic valve stenosis. J Cardiovasc Dev Dis. 2022;9(4):116. https:\/\/doi.org\/10.3390\/jcdd9040116. Published 2022 Apr 14.","journal-title":"J Cardiovasc Dev Dis"},{"issue":"1","key":"1919_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.amjcard.2017.09.018","volume":"121","author":"PM Donnelly","year":"2018","unstructured":"Donnelly PM, Kolossv\u00e1ry M, Kar\u00e1dy J, et al. Experience with an on-site coronary computed tomography-derived fractional flow reserve algorithm for the assessment of intermediate coronary stenoses. The Am J Cardiol. 2018;121(1):9\u201313. https:\/\/doi.org\/10.1016\/j.amjcard.2017.09.018.","journal-title":"The Am J Cardiol"},{"issue":"1","key":"1919_CR24","doi-asserted-by":"publisher","first-page":"18323","DOI":"10.1038\/s41598-020-75266-4","volume":"10","author":"J Lee","year":"2020","unstructured":"Lee J, Kim HS, Cho YK, et al. Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease. Sci Rep. 2020;10(1):18323.","journal-title":"Sci Rep"},{"issue":"3","key":"1919_CR25","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1148\/radiol.14140933","volume":"274","author":"SB Puchner","year":"2015","unstructured":"Puchner SB, Lu MT, Mayrhofer T, et al. High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial. Radiology. 2015;274(3):693\u2013701.","journal-title":"Radiology"},{"issue":"11","key":"1919_CR26","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.mayocp.2013.06.025","volume":"88","author":"R Chhabra","year":"2013","unstructured":"Chhabra R, O\u2019Keefe JH, Patil H, et al. Association of coronary artery calcification with hepatic steatosis in asymptomatic individuals. Mayo Clin Proc. 2013;88(11):1259\u201365.","journal-title":"Mayo Clin Proc"},{"key":"1919_CR27","doi-asserted-by":"publisher","first-page":"155370","DOI":"10.1016\/j.metabol.2022.155370","volume":"139","author":"G Huangfu","year":"2023","unstructured":"Huangfu G, Jaltotage B, Pang J, et al. Hepatic fat as a novel marker for high-risk coronary atherosclerotic plaque features in familial hyper-cholesterolaemia. Metabolism. 2023;139:155370.","journal-title":"Metabolism"},{"issue":"11","key":"1919_CR28","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","volume":"2","author":"H Yki-J\u00e4rvinen","year":"2014","unstructured":"Yki-J\u00e4rvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2014;2(11):901\u201310.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"1919_CR29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u201309.","journal-title":"J Hepatol"},{"issue":"3","key":"1919_CR30","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1148\/radiol.10101233","volume":"258","author":"YS Park","year":"2011","unstructured":"Park YS, Park SH, Lee SS, et al. Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT. Radiology. 2011;258(3):760\u201366.","journal-title":"Radiology"},{"issue":"3","key":"1919_CR31","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2214\/AJR.09.2590","volume":"194","author":"CJ Boyce","year":"2010","unstructured":"Boyce CJ, Pickhardt PJ, Kim DH, et al. Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J roentgenol. 2010;194(3):623\u201328.","journal-title":"AJR Am J roentgenol"},{"key":"1919_CR32","doi-asserted-by":"publisher","unstructured":"GBD. Stroke risk factor collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2021. A systematic analysis for the global burden of disease study 2021. The Lancet Neurol. 2024;23(10):973\u20131003. https:\/\/doi.org\/10.1016\/S1474-4422(24)00369-7.","DOI":"10.1016\/S1474-4422(24)00369-7"},{"key":"1919_CR33","doi-asserted-by":"publisher","unstructured":"Whelton PK, Carey RM, Aronow WS, et al. ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: A report of the American college of Cardiology\/American heart association task force on clinical practice guidelines. Hypertension. 2017. 2018;71(6):1269\u2013324. https:\/\/doi.org\/10.1161\/HYP.0000000000000066.","DOI":"10.1161\/HYP.0000000000000066"},{"key":"1919_CR34","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20\u201342. https:\/\/doi.org\/10.2337\/dc24-S002.","DOI":"10.2337\/dc24-S002"},{"issue":"11","key":"1919_CR35","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.jcmg.2016.11.024","volume":"10","author":"MT Lu","year":"2017","unstructured":"Lu MT, Ferencik M, Roberts RS, et al. Noninvasive FFR derived from coronary CT angiography. Management and outcome from the PROMISE trial. JACC Cardiovasc imaging. 2017;10(11):1350\u201358.","journal-title":"JACC Cardiovasc imaging"},{"issue":"6","key":"1919_CR36","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jcct.2016.10.002","volume":"10","author":"S Abbara","year":"2016","unstructured":"Abbara S, Blanke P, Maroules CD, et al. SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: a report of the society of cardiovascular computed tomography guidelines committee: endorsed by the North American society for cardiovascular imaging (NASCI). J Cardiovasc Comput tomogr. 2016;10(6):435\u201349.","journal-title":"J Cardiovasc Comput tomogr"},{"issue":"18","key":"1919_CR37","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231\u201364.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1919_CR38","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1136\/gutjnl-2021-325724","volume":"71","author":"TG Simon","year":"2022","unstructured":"Simon TG, Roelstraete B, Hagstr\u00f6m H, et al. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort. Gut. 2022;71(9):1867\u201375.","journal-title":"Gut"},{"issue":"3","key":"1919_CR39","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1148\/radiol.2021210355","volume":"301","author":"MM Yu","year":"2021","unstructured":"Yu MM, Tang XL, Jin H, et al. Coronary CT angiography in asymptomatic adults with hepatic steatosis. Radiology. 2021;301(3):593\u2013601.","journal-title":"Radiology"},{"issue":"3","key":"1919_CR40","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/heartjnl-2021-319773","volume":"108","author":"BL N\u00f8rgaard","year":"2022","unstructured":"N\u00f8rgaard BL, Gaur S, Fairbairn TA, et al. Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta- analysis. Heart. 2022;108(3):194\u2013202.","journal-title":"Heart"},{"issue":"21","key":"1919_CR41","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1161\/CIRCULATIONAHA.117.030578","volume":"136","author":"MJ Budoff","year":"2017","unstructured":"Budoff MJ, Mayrhofer T, Ferencik M, et al. Prognostic value of coronary artery calcium in the PROMISE study (prospective multicenter imaging study for evaluation of chest pain). Circulation. 2017;136(21):1993\u20132005.","journal-title":"Circulation"},{"issue":"1","key":"1919_CR42","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12933-024-02354-4","volume":"23","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang F, Tang J, Shen L, He J, Chen Y. Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999-2018. Cardiovasc diabetol. 2024;23(1):262. https:\/\/doi.org\/10.1186\/s12933-024-02354-4. Published 2024 Jul 18.","journal-title":"Cardiovasc diabetol"},{"key":"1919_CR43","doi-asserted-by":"publisher","first-page":"e076388","DOI":"10.1136\/bmj-2023-076388","volume":"384","author":"KS Kim","year":"2024","unstructured":"Kim KS, Hong S, Han K, Park CY. Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study. BMJ. 2024;384:e076388. https:\/\/doi.org\/10.1136\/bmj-2023-076388. Published 2024 Feb 13.","journal-title":"BMJ"},{"issue":"9","key":"1919_CR44","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1136\/gutjnl-2018-317666","volume":"68","author":"Y Chang","year":"2019","unstructured":"Chang Y, Ryu S, Sung KC, et al. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the kangbuk samsung health study. Gut. 2019;68(9):1667\u201375. https:\/\/doi.org\/10.1136\/gutjnl-2018-317666.","journal-title":"Gut"},{"issue":"3","key":"1919_CR45","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S1076-6332(03)00714-1","volume":"11","author":"C Hong","year":"2004","unstructured":"Hong C, Pilgram TK, Zhu F, Bae KT. Is coronary artery calcium mass related to Agatston score? Acad Radiol. 2004;11(3):286\u201392.","journal-title":"Acad Radiol"},{"issue":"7","key":"1919_CR46","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s10554-013-0240-8","volume":"29","author":"R Cerci","year":"2013","unstructured":"Cerci R, Vavere AL, Miller JM, et al. Patterns of coronary arterial lesion calcification by a novel, cross-sectional CT angiographic assessment. Int J Cardiovasc imaging. 2013;29(7):1619\u201327.","journal-title":"Int J Cardiovasc imaging"},{"issue":"4","key":"1919_CR47","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jacc.2015.05.069","volume":"66","author":"S Motoyama","year":"2015","unstructured":"Motoyama S, Ito H, Sarai M, et al. Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up. J Am Coll Cardiol. 2015;66(4):337\u201346.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1919_CR48","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.jcmg.2024.06.012","volume":"17","author":"S Sukudom","year":"2024","unstructured":"Sukudom S, Wee J, Huangfu G, et al. Hepatic steatosis and high-risk coronary plaque: a systematic review. JACC Cardiovasc imaging. 2024;17(11):1392\u201394.","journal-title":"JACC Cardiovasc imaging"},{"issue":"4","key":"1919_CR49","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jcmg.2012.09.016","volume":"6","author":"K Otsuka","year":"2013","unstructured":"Otsuka K, Fukuda S, Tanaka A, et al. Napkin-ring sign on coronary CT angiography for the prediction of acute coronary syndrome. JACC Cardiovasc imaging. 2013;6(4):448\u201357.","journal-title":"JACC Cardiovasc imaging"},{"issue":"2","key":"1919_CR50","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1001\/jamacardio.2017.4973","volume":"3","author":"M Ferencik","year":"2018","unstructured":"Ferencik M, Mayrhofer T, Bittner D O, et al. Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial. JAMA Cardiol. 2018;3(2):144\u201352.","journal-title":"JAMA Cardiol"},{"issue":"10","key":"1919_CR51","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.4254\/wjh.v7.i10.1325","volume":"7","author":"L Polimeni","year":"2015","unstructured":"Polimeni L, Del Ben M, Baratta F, et al. Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis. World J Hepatol. 2015;7(10):1325\u201336.","journal-title":"World J Hepatol"},{"key":"1919_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.atherosclerosis.2015.12.028","volume":"246","author":"L Bhatia","year":"2016","unstructured":"Bhatia L, Scorletti E, Curzen N, et al. Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression. Atherosclerosis. 2016;246:13\u201320.","journal-title":"Atherosclerosis"},{"issue":"7","key":"1919_CR53","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.cgh.2020.07.030","volume":"19","author":"NM Meyersohn","year":"2021","unstructured":"Meyersohn NM, Mayrhofer T, Corey KE, et al. Association of hepatic steatosis with major adverse cardiovascular events, independent of coronary artery disease. Clin Gastroenterol Hepatol. 2021;19(7):1480\u20138.e14.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1919_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1478-3231.2008.01949.x","volume":"29","author":"ZM Younossi","year":"2009","unstructured":"Younossi ZM, McCullough AJ. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response. Liver Int. 2009;29 Suppl, 2: 3\u201312.","journal-title":"Liver Int"},{"issue":"6","key":"1919_CR55","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","volume":"42","author":"PB Duell","year":"2022","unstructured":"Duell PB, Welty FK, Miller M, et al. Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American heart association. Arterioscler Thromb Vasc Biol. 2022;42(6):e168\u201385.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1919_CR56","first-page":"335","volume":"76","author":"SM Francque","year":"2022","unstructured":"Francque SM, van der Graaff D, Kwanten WJ. Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications. J Hepatol. 2022;76(1):335\u201357.","journal-title":"J Hepatol"},{"issue":"4","key":"1919_CR57","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/hep4.1155","volume":"2","author":"YY Zhou","year":"2018","unstructured":"Zhou YY, Zhou XD, Wu SJ, et al. Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: a systematic review and meta-analysis. Hepatol Commun. 2018;2(4):376\u201392.","journal-title":"Hepatol Commun"},{"issue":"6","key":"1919_CR58","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66(6):1138\u201353.","journal-title":"Gut"},{"issue":"10","key":"1919_CR59","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.scib.2024.03.053","volume":"69","author":"B Guo","year":"2024","unstructured":"Guo B, Jiang M, Guo X, et al. Diagnostic and prognostic performance of artificial intelligence-based fully-automated on-site CT-FFR in patients with CAD. Sci Bull. 2024;69(10):1472\u201385.","journal-title":"Sci Bull"},{"issue":"6","key":"1919_CR60","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/RTI.0000000000000679","volume":"37","author":"LJ Zhang","year":"2022","unstructured":"Zhang LJ, Tang C, Xu P, et al. Coronary computed tomography angiography-derived fractional flow reserve: an expert consensus document of the Chinese society of radiology. J Thorac imaging. 2022;37(6):385\u2013400.","journal-title":"J Thorac imaging"},{"issue":"4","key":"1919_CR61","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cld.2009.07.009","volume":"13","author":"K Cusi","year":"2009","unstructured":"Cusi K. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. Clin Liver Dis. 2009;13(4):545\u201363. https:\/\/doi.org\/10.1016\/j.cld.2009.07.009.","journal-title":"Clin Liver Dis"},{"issue":"1","key":"1919_CR62","doi-asserted-by":"publisher","first-page":"2192444","DOI":"10.1080\/10641963.2023.2192444","volume":"45","author":"W Jiang","year":"2023","unstructured":"Jiang W, Zhang Y, Zhang W, et al. Hirsutine ameliorates myocardial ischemia-reperfusion injury through improving mitochondrial function via CaMKII pathway. Clin Exp Hypertens. 2023;45(1):2192444. https:\/\/doi.org\/10.1080\/10641963.2023.2192444.","journal-title":"Clin Exp Hypertens"},{"key":"1919_CR63","doi-asserted-by":"publisher","unstructured":"Peng H, Chen L, Deng Y, Liao X, Yang Y. Ginsenoside Rh2 mitigates myocardial damage in acute myocardial infarction by regulating pyroptosis of cardiomyocytes. Clin Exp Hypertens. 2023;45(1):2229536. https:\/\/doi.org\/10.1080\/10641963.2023.2229536.","DOI":"10.1080\/10641963.2023.2229536"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01919-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01919-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01919-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:04:58Z","timestamp":1759176298000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01919-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1919"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01919-3","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was a retrospective analysis and received approval from the Ethics Committee of Dalian Medical University (Approval No. PJ-KS-KY-2024\u2013432). The requirement for informed consent was waived by the Ethics Committee due to the retrospective nature of the study, in accordance with relevant national regulations. The procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"398"}}